Yahoo Web Search

Search results

  1. 1 day ago · Anavex Life Sciences (AVXL) Company Description: Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the ...

  2. 1 day ago · Anavex's blarcamesine unlike Cassava Sciences' simufilam and Annovis's butanentap may nearly stabilize mild cognitive impairment and mild Alzheimer's disease for three years because it probably ...

  3. 1 day ago · According to the issued ratings of 1 analysts in the last year, the consensus rating for Anavex Life Sciences stock is Buy based on the current 1 buy rating for AVXL. The average twelve-month price prediction for Anavex Life Sciences is $40.00 with a high price target of $40.00 and a low price target of $40.00.

  4. 1 day ago · 1 Wall Street analysts have issued 1-year target prices for Anavex Life Sciences' shares. Their AVXL share price targets range from $40.00 to $40.00. On average, they anticipate the company's share price to reach $40.00 in the next year. This suggests a possible upside of 949.9% from the stock's current price.

    • (844) 689-3939
    • 51 W 52ND STREET 7TH FLOOR, NEW YORK NY, 10019
    • ir@anavex.com
  5. People also ask

  6. 1 day ago · Billion Dollar Secret. View Anavex Life Sciences Corp AVXL investment & stock information. Get the latest Anavex Life Sciences Corp AVXL detailed stock quotes, stock data, Real-Time ECN, charts ...

  7. 1 day ago · Anavex Life Sciences Corp. isn't one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning.

  8. 4 days ago · View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations. Get daily stock ideas from top-performing Wall Street analysts.

  1. People also search for